Loading...
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
After that the era of chemotherapy in the treatment of solid tumors have been overcome by the “translational era”, with the innovation introduced by targeted therapies, medical oncology is currently looking at the dawn of a new “immunotherapy era” with the advent of immune checkpoint inhibitors (CKI...
Na minha lista:
| Udgivet i: | World J Clin Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5309713/ https://ncbi.nlm.nih.gov/pubmed/28246584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v8.i1.37 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|